MyMD Pharmaceuticals announced the appointment of Mitchell Glass, a member of the board of directors of the company, as president and chief medical officer. The company also announced the appointment of Stephen Friscia, a veteran investor, to the board of directors.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYMD: